What is the primary goal of conducting biomedical studies not performed on human subjects?

The primary goal of conducting biomedical studies not performed on human subjects is to ensure safety and efficacy before human trials. Preclinical studies, which often use animal models or in vitro systems, play a crucial role in the drug development process. They allow researchers to evaluate the biological activity, potential toxicity, formulation, pharmacokinetics, and pharmacodynamics of new therapies before they are tested in humans.

By conducting these studies, researchers aim to identify any safety concerns and assess the effectiveness of the intervention, which helps to mitigate risks when moving into human trials. This step is essential to protect participants and ensure that only the most promising and safest candidates for treatment are advanced to clinical research involving human subjects.

While options related to simplifying research processes, gathering information for drug development, and maximizing data collection efficiency touch on aspects of the research process, they do not directly address the critical need for safety and efficacy determination, which underpins the rationale for preclinical studies.